BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230328
DTEND;VALUE=DATE:20230330
DTSTAMP:20260516T052348
CREATED:20221213T120801Z
LAST-MODIFIED:20221213T120801Z
UID:36077-1679961600-1680134399@www.pharmajournalist.com
SUMMARY:Reuters Events: Pharma USA 2023
DESCRIPTION:Patient-first. Collaborative. Data and insights driven. Digitally underpinned. \nThese are the qualities of a healthcare system that actively serves its purpose – yet instead\, the US is hindered by mounting financial toxicity\, unprecedented politicization of science and eroding public trust. \nTo capitalize on three years of extraordinary momentum and lead healthcare’s reform\, pharma must embody the traits that healthcare needs to thrive and restructure in pursuit of change. \nSeize the moment at Reuters Events: Pharma USA 2023 to lead pharma’s internal revolution and drive this critical systemic transformation. Join North America’s visionary pharma changemakers\, leading solution providers\, patient experts and industry heavyweights to catapult commercial excellence\, ingrain patient-first strategies into the heart of pharma’s fabric and heed the long-awaited rebirth of America’s healthcare system. \nTo know more visit: https://bit.ly/3uJUp5O
URL:https://www.pharmajournalist.com/event/reuters-events-pharma-usa-2023/
LOCATION:Pennsylvania Convention Center\, 1101 Arch St\, Philadelphia\, PA\, 19107\, United States
ORGANIZER;CN="Reuters Events":MAILTO:Tahmeena.Miah@ThomsonReuters.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230328
DTEND;VALUE=DATE:20230331
DTSTAMP:20260516T052348
CREATED:20230310T091100Z
LAST-MODIFIED:20230310T091100Z
UID:36791-1679961600-1680220799@www.pharmajournalist.com
SUMMARY:8th Innate Killer Summit
DESCRIPTION:Dedicated to driving cost-effective\, efficacious\, safe\, durable\, scalable\, and globally accessible allogeneic\, cell-based\, and engager therapies\, the 8th Innate Killer Summit returns to cement your end-to-end education in innate immune therapeutics. Your industry-defining Innate Killer Summit brings crucial insights for everyone on your team\, with 4 content tracks spanning preclinical development\, clinical translation\, CMC\, process development\, and clinical scale manufacturing\, this is the definitive meeting to drive concept to commercial success of emerging innate immune therapies. \nDownload your copy of the Full Event Guide here. \nJoin over 250 experts from 120+ pioneering companies to drive novel gene engineering technologies\, gain regulatory know-how\, optimize lymphodepletion and cryopreservation\, and contrast cell sources for highly efficacious\, scalable off-the-shelf therapies. \nPromising brand-new speakers from new companies\, interactive discussion\, and engaging networking opportunities\, attend to forge new collaborations and realize the clinical potential of innate immune therapies. \nRegister your place here.
URL:https://www.pharmajournalist.com/event/8th-innate-killer-summit/
LOCATION:HILTON LA JOLLA TORREY PINES\, 10950 N. Torrey Pines Road\, La Jolla\, CA\, 92037\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR